SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-118577
Filing Date
2023-04-26
Accepted
2023-04-26 16:28:15
Documents
18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d479013ddef14a.htm   iXBRL DEF 14A 767285
6 GRAPHIC g479013g02s02.jpg GRAPHIC 77694
7 GRAPHIC g479013g36a61.jpg GRAPHIC 128979
8 GRAPHIC g479013g56a01.jpg GRAPHIC 172975
9 GRAPHIC g479013g56a02.jpg GRAPHIC 131576
  Complete submission text file 0001193125-23-118577.txt   2665150

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rvmd-20221231.xsd EX-101.SCH 4565
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rvmd-20221231_def.xml EX-101.DEF 4075
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rvmd-20221231_lab.xml EX-101.LAB 5634
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rvmd-20221231_pre.xml EX-101.PRE 3332
12 EXTRACTED XBRL INSTANCE DOCUMENT d479013ddef14a_htm.xml XML 157171
Mailing Address 700 SAGINAW DR REDWOOD CITY CA 94063
Business Address 700 SAGINAW DR REDWOOD CITY CA 94063 415-766-3638
Revolution Medicines, Inc. (Filer) CIK: 0001628171 (see all company filings)

IRS No.: 472029180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39219 | Film No.: 23850156
SIC: 2836 Biological Products, (No Diagnostic Substances)